The weight loss drug Wegovy is now available as a tablet in more than 70,000 U.S. pharmacies as well as select telehealth ...

Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...

Novo Nordisk’s oral Wegovy pill for weight loss is now available by prescription, offering a non-injectable GLP-1 option.

The lowest doses of the daily pill will cost $149 a month for people paying out of pocket, offering a cheaper alternative to ...

The FDA has approved the first prescription weight‑loss pill using the same medication found in injectable GLP‑1 drugs, marking a major shift in how millions of Americans may access treatment. The ...

The U.S. Food and Drug Administration approved the Wegovy pill in late December 2025 for adults who are obese or overweight ...

THE PILL AND injectable forms of Wegovy have similar side effects—most commonly, nausea, vomiting, and diarrhea, Dr. Park ...

Novo Nordisk has launched its first oral GLP-1 weight-loss pill in the United States, expanding beyond injectable treatments ...

Novo Nordisk announced its popular GLP-1 injectable Wegovy is now available in pill form with a prescription at more than ...

Low-income Californians who use Wegovy and similar weight loss drugs will lose their coverage in January. California and ...